Authors
»
[No authors listed]
Category
»
Primary study
Registry of Trials»Iranian Registry of Clinical Trials
Year
»
2010
INTERVENTION: In the first cycle of the study, patients received one of the antiemetic regimen, regimen A (routine + 1 gr ginger ) or regimen B (routine +1gr Placebos) In the next cycle of chemotherapy , 28 days after the previous cycle another regimen (A or B ) administrated together with chemotherapy drugs Intervention 1: In the first cycle of the study, patients received one of the antiemetic regimen, regimen A (routine + 1 gr ginger ) or regimen B (routine +1gr Placebos). Intervention 2: In the next cycle of chemotherapy , 28 days after the previous cycle another regimen (A or B ) administrated together with chemotherapy drugs. Treatment ‐ Drugs CONDITION: coo‐c97 neoplasm. ; c97 PRIMARY OUTCOME: Nausae and vomiting. Timepoint: 1, 2, 3, 4, 24 hours. Method of measurement: cheklist. SECONDARY OUTCOME: Nausea and vomiting. Timepoint: 28 days after first dose drugs , (change regime A,B) and after that for 1, 2,3,4 and 24 after that , nause and vomit was assessed. Method of measurement: cortilla tool. INCLUSION CRITERIA: INCLUSION CRITERIA: age more than 18 years old, having experience of chemotherapy along with nausea and vomit, having minimum two chemotherapy periods containing of 50‐100 milligram per square meter of sys‐platinum, individually or along with other factors of chemotherapy with the similar amount and method of prescription in two chemotherapy cycles without any plan for radiotherapy between two cycles, Remaining in the ward for a period of 24 hours (in order to study of the PRN anti‐nausea drugs), Not having nausea and vomit for reasons other than chemotherapy, non‐receiving anti‐nausea and anti‐vomit drugs during the past 24 hours, not receiving treatment with Corticosteroid Drugs during the studied cycles, not‐suffering from Hepatitis, obstruction of digestion system, cerebral malignancy or cerebral metastasis and coagulation disorders (plaque less than 100000 per cubic millimeter) based on the registered information in the file and not consuming any anti‐coagulat
Epistemonikos ID: ecf21600d956165f9ba90cdc494304bdde5af1d2
First added on: Aug 22, 2024